期刊文献+

关于我国血友病诊疗的几点思考 被引量:1

Reflections on diagnosis and treatment of hemophilia in China
下载PDF
导出
摘要 近年来我国血友病防治水平有了较大提升,作者结合国内外研究现状和我国实际提出了对现阶段我国血友病诊疗的几点思考,包括女性血友病概念的提出及分型、如何进行规律替代治疗以及如何进行抑制物清除。通过对上述几个问题的思考,作者提出我国现阶段不宜盲目提倡大剂量预防治疗,但必须尽早开始预防治疗;此外还应该大力提倡和推广携带者检测和产前诊断,以期降低我国血友病的发病率。
作者 杨仁池 Yang Ren-chi(Hematology Hospital,Chinese Academy of Medical Science(Institute of Hematology,Chinese Academy of Medical Science),Tianjin 300020,China)
出处 《血栓与止血学》 CAS 2022年第5期1135-1138,共4页 Chinese Journal of Thrombosis and Hemostasis
基金 中国医学科学院医学与健康科技创新工程项目(2021-I2M-003)。
  • 相关文献

参考文献5

二级参考文献23

  • 1Rocino A,Santagostino E,Mancuso ME,et al.Immune tolerance induction with recombinant factor Ⅷ in hemophilia A patients with high responding inhibitors.Haematologica,2006,91:558-561.
  • 2Gouw SC,van den Berg HM.The multifactorial etiology of inhibitor development in hemophilia:genetics and environment.Semin Thromb Hemost,2009,35:723-734.
  • 3Wang XF,Zhao YQ,Yang RC,et al.The prevalence of factor Ⅷ inhibitors and genetic aspects of inhibitor development in Chinese patients with haemophilia A.Haemophilia,2010,16:632-639.
  • 4Dasgupta S,Repessé Y,Bayry J,et al.vWF protects FⅧ from endocytosis by dendritic cells and subsequent presentation to immune effectors.Blood,2007,109:610-612.
  • 5Lacroix-Desmazes S,Navarrete AM,André S,et al.Dynamics of factor Ⅷ interactions determine its immunologic fate in hemophilia A.Blood,2008,112:240-249.
  • 6Ghosh K,Shetty S.Immune response to FⅧ in hemophilia A:an overview of risk factors.Clin Rev Allergy Immunol,2009,37:58-66.
  • 7Goudemand J,Rothschild C,Demiguel V,et al.Influence of the type of factor Ⅷ concentrate on the incidence of factor Ⅷ inhibitors in previously untreated patients with severe hemophilia A.Blood,2006,107:46-51.
  • 8Tellier Z,André MH,Polack B.Management of haemophilia Ainhibitor patients:clinical and regulatory perspectives.Clin Rev Allergy Immunol,2009,37:125-134.
  • 9Franchini M.Recombinant factor Ⅶa:a review on its clinical use.Int J Hematol,2006,83:126-138.
  • 10Abshire T,Kenet G.Safety update on the use of recombinant factor Ⅶa and the treatment of congenital and acquired deficiency of factor Ⅷ or Ⅸ with inhibitors.Haemophilia,2008,14:898-902.

共引文献142

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部